Spanish Police Arrest Suspect for Marijuana Cultivation and Drug Production

Regulations by 2FIRSTS.ai

Jan.11.2024

Spanish Police Arrest Suspect for Marijuana Cultivation and Drug Production

Spanish police arrested a 41-year-old man in Villanueva del Río Segura in a successful drug raid.

According to a report by the Spanish media outlet La Razon on January 10th, Spanish police arrested a 41-year-old man in Villanueva del Río Segura during a successful operation targeting cannabis cultivation, drug manufacturing, and illegal electricity theft. The operation began at midnight when a riot police team, during their patrol in the area, came across several garbage bags filled with cannabis in a dark corner. Subsequently, they seized ten bags and initiated an investigation.

During the investigation, the police discovered another six bags filled with marijuana in the area, leading them to uncover a hidden house. Upon searching the premises, law enforcement found 361 flowering cannabis plants along with associated cultivation equipment such as halogen lamps, ozone filters, activated carbon filters, and cooling devices.

A 41-year-old man who was arrested has become the prime suspect in an alleged marijuana crime. He is accused of engaging in marijuana cultivation and drug manufacturing, as well as being involved in illegal electricity theft. The police have handed over the suspect, seized drugs, and relevant evidence to the Cieza court for further trial.

The successful operation is a strong blow against drug crime and showcases the sharp observation and decisive action of the Spanish police towards criminal activities.

References:

[1] Hallan una vivienda en Murcia con 400 plantas de marihuana en su interior

Also Read:

[1] PMI Spain CEO: Collaborating with New Health Minister for Public Health

[2] Philip Morris Spain CEO Daniel Cuevas Advocates for Stronger Tobacco Regulations

#Europe #Law enforcement #Spain #Marijuana #Medical marijuana dispensary #Product

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn

Notice

1. This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2. The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3. This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4. Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

Copyright

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

AI Assistance Disclaimer

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

U.S. FDA Includes Cytisinicline for Vaping Addiction in National Priority Voucher Program, Shortens Review to 1–2 Months

The U.S. Food and Drug Administration (FDA) has added Cytisinicline, a plant-based therapy developed by Achieve Life Sciences for nicotine vaping addiction, to its new National Priority Voucher (CNPV) program. The initiative shortens drug review timelines from 10–12 months to just 1–2 months, expediting approval for treatments that address major public health needs.

Oct.20 by 2FIRSTS.ai

JTI launches Ploom AURA new heated tobacco device device in Romania

Japan Tobacco International（JTI） introduces Ploom AURA in Romania, combining SMART HEATFLOW technology to preserve tobacco flavor, aiming at high-end consumers.

Oct.17 by 2FIRSTS.ai

Germany OLG Cologne: Touchscreen Vape Use Violates Driving “Phone Ban”

Germany’s OLG Cologne ruled that adjusting an e-cigarette touchscreen while driving violates the “phone ban” under road traffic law. The driver, caught changing vape settings on the highway, was fined €150 and received one penalty point, as the court said such actions pose significant distraction risks.

Oct.27 by 2FIRSTS.ai

Imperial Brands launches ZONE nicotine pouches in the UK, covering the core 9–12 mg strength segment

Imperial Brands has launched its ZONE nicotine pouches in the UK, targeting the mainstream 9–12 mg nicotine strength segment. The brand debuts with five flavours at a recommended retail price of £6.50 per can. Mint variants currently account for around 70% of UK nicotine pouch sales, while fruit flavours are growing rapidly. ZONE will be distributed primarily through independent retail channels.